Severity and geographical disparities of post-COVID-19 symptoms among the Vietnamese general population: a national evaluation.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
17 03 2023
17 03 2023
Historique:
received:
14
12
2022
accepted:
01
03
2023
entrez:
18
3
2023
pubmed:
19
3
2023
medline:
22
3
2023
Statut:
epublish
Résumé
Post-COVID-19 symptoms have become a significant global health concern. This study focused on assessing the prevalence, severity, and care preference of post-COVID-19 symptoms, as well as identifying determinants to inform evidence-based policy on post-COVID-19 in Vietnam. A national cross-sectional study was conducted in May 2022 among 12,361 recovered COVID-19 patients, providing the largest dataset on health status after COVID-19 in Vietnam. The study utilized ordered logistic, Poisson regression, Multilevel linear random-effects models, and Multilevel random effects ordered logistic model to identify factors associated with various aspects of post-COVID-19 conditions. Results showed that the average number of post-COVID-19 symptoms was approximately 3, with fatigue and headache being the most common symptoms. The number of post-COVID-19 symptoms varied by province, decreased with age, and was significantly correlated with the duration of infection. Age, infection period, underlying conditions, telehealth utilization, and geographical location were identified as significant determinants of post-COVID-19 symptoms. The study concluded that improving resource allocation and health-seeking behavior in underserved areas could help address differences in health outcomes and improve post-COVID-19 control in Vietnam.
Identifiants
pubmed: 36932094
doi: 10.1038/s41598-023-30790-x
pii: 10.1038/s41598-023-30790-x
pmc: PMC10022561
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
4460Informations de copyright
© 2023. The Author(s).
Références
Ann Thorac Med. 2021 Jul-Sep;16(3):260-265
pubmed: 34484441
Lancet Infect Dis. 2022 Apr;22(4):e102-e107
pubmed: 34951953
Circulation. 2021 May 25;143(21):e984-e1010
pubmed: 33882682
Headache. 1995 Jan;35(1):29-35
pubmed: 7868331
Int J Environ Res Public Health. 2021 Apr 20;18(8):
pubmed: 33923972
BMJ. 2020 Dec 23;371:m4938
pubmed: 33361141
BMJ Glob Health. 2021 Sep;6(9):
pubmed: 34580069
Occup Med (Lond). 2021 Jun 16;71(3):144-146
pubmed: 33830208
Nature. 2020 Dec;588(7837):315-320
pubmed: 32846427
Thorax. 2021 Apr;76(4):408-411
pubmed: 33542090
Lancet. 2021 Aug 28;398(10302):747-758
pubmed: 34454673
Radiology. 1999 Feb;210(2):307-22
pubmed: 10207408
Am J Gastroenterol. 2013 Mar;108(3):308-28; quiz 329
pubmed: 23419381
BMC Med. 2022 Feb 4;20(1):50
pubmed: 35114994
Ann Intern Med. 1985 Dec;103(6 ( Pt 2)):1034-6
pubmed: 4062120
Pathogens. 2022 Feb 19;11(2):
pubmed: 35215212
Psychiatr Pol. 2020 Apr 30;54(2):187-198
pubmed: 32772053
J Med Virol. 2021 Mar;93(3):1242-1243
pubmed: 33034893
Oncologist. 2011;16(6):726-9
pubmed: 21632448
Acta Otolaryngol. 2005 Jan;125(1):55-9
pubmed: 15799575
BMJ. 2020 Jul 14;370:m2815
pubmed: 32665317
Int J Hosp Manag. 2021 May;95:102909
pubmed: 33678936
Qual Life Res. 2021 Mar;30(3):643-645
pubmed: 33073307
Int J Environ Res Public Health. 2020 Nov 24;17(23):
pubmed: 33255233
J Med Virol. 2021 May;93(5):2555-2556
pubmed: 33095459
Eur J Intern Med. 2021 Oct;92:55-70
pubmed: 34167876
PLoS One. 2021 Aug 4;16(8):e0254821
pubmed: 34347812
Lancet Reg Health Eur. 2021 Jul;6:100122
pubmed: 34027514
BMJ Glob Health. 2021 Jan;6(1):
pubmed: 33495284
Nat Immunol. 2021 Mar;22(3):261
pubmed: 33627879